Cargando…
Use of anti-tuberculosis drugs among newly diagnosed pulmonary tuberculosis inpatients in China: a retrospective study
BACKGROUND: China’s national tuberculosis control program (NTP) provides free, first-line anti-tuberculosis (TB) drugs to pulmonary TB patients. This treatment regimen follows the World Health Organization’s (WHO) guideline. The objective of this paper is to evaluate the current status of anti-TB dr...
Autores principales: | Huang, Fei, Zhang, Hui, Lv, Qing, Sato, Kaori D., Qu, Yan, Huan, Shitong, Cheng, Jun, Zhao, Fei, Wang, Lixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720996/ https://www.ncbi.nlm.nih.gov/pubmed/26792535 http://dx.doi.org/10.1186/s40249-016-0098-9 |
Ejemplares similares
-
Accuracy of Commercial Molecular Diagnostics for the Detection of Pulmonary Tuberculosis in China: A Systematic Review
por: Deng, Siwei, et al.
Publicado: (2019) -
Hematological manifestations in patients newly diagnosed with pulmonary tuberculosis
por: Batool, Yasmeen, et al.
Publicado: (2022) -
Bilateral Pulmonary Embolism in a Newly Diagnosed Case of Pulmonary Tuberculosis
por: Zahra, Urooj, et al.
Publicado: (2021) -
Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis
por: Jaimni, Vijay, et al.
Publicado: (2021) -
Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis
por: Sharma, Surendra K., et al.
Publicado: (2011)